- Home
- LUCK vs AMPH Comparison
LUCK vs AMPH Comparison
Compare LUCK & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCK
- AMPH
- Stock Information
- Founded
- LUCK 1997
- AMPH 1996
- Country
- LUCK United States
- AMPH United States
- Employees
- LUCK N/A
- AMPH N/A
- Industry
- LUCK
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- LUCK
- AMPH Health Care
- Exchange
- LUCK NYSE
- AMPH Nasdaq
- Market Cap
- LUCK 1.3B
- AMPH 1.1B
- IPO Year
- LUCK N/A
- AMPH 2014
- Fundamental
- Price
- LUCK $9.29
- AMPH $23.18
- Analyst Decision
- LUCK Strong Buy
- AMPH Hold
- Analyst Count
- LUCK 3
- AMPH 5
- Target Price
- LUCK $12.67
- AMPH $38.00
- AVG Volume (30 Days)
- LUCK 298.3K
- AMPH 500.2K
- Earning Date
- LUCK 05-08-2025
- AMPH 08-06-2025
- Dividend Yield
- LUCK 2.36%
- AMPH N/A
- EPS Growth
- LUCK N/A
- AMPH N/A
- EPS
- LUCK N/A
- AMPH 2.77
- Revenue
- LUCK $1,184,019,000.00
- AMPH $730,659,000.00
- Revenue This Year
- LUCK $6.36
- AMPH $0.67
- Revenue Next Year
- LUCK $5.94
- AMPH $5.18
- P/E Ratio
- LUCK N/A
- AMPH $8.35
- Revenue Growth
- LUCK 6.65
- AMPH 8.05
- 52 Week Low
- LUCK $7.66
- AMPH $22.64
- 52 Week High
- LUCK $14.92
- AMPH $53.96
- Technical
- Relative Strength Index (RSI)
- LUCK N/A
- AMPH 33.77
- Support Level
- LUCK N/A
- AMPH $24.35
- Resistance Level
- LUCK N/A
- AMPH $25.04
- Average True Range (ATR)
- LUCK 0.00
- AMPH 0.72
- MACD
- LUCK 0.00
- AMPH -0.33
- Stochastic Oscillator
- LUCK 0.00
- AMPH 3.43
About LUCK LUCKY STRIKE ENTERTAINMENT CORPORAT
Lucky Strike Entertainment Corp is a entertainment platforms. It has nearly 360 locations across North America, that provides experiential offerings in bowling, amusements, water parks, and family entertainment centers. The company also owns the Professional Bowlers Association, the league of bowling and a growing media property.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.